court of appeals

The plaintiffs say the USPTO made several errors when it determined the Broad Institute had the right to patent the use of CRISPR/Cas9 in eukaryotes.

The so-called '540 patent has been the focal point of a series of lawsuits between Sequenom and other NIPT firms since 2011. 

NEW YORK (GenomeWeb News) – A federal appeals court today has for a second time reversed a lower district court's decision that isolated genes are not patentable, but it also partly affirmed the District Court's decision that certain methods patents "comparing" or "analyzing" gene sequences may n

The US Court of Appeals reversed the earlier decision in the case challenging Myriad's BRCA patents, saying that isolated DNA is patent eligible under US law.

Myriad Genetics and the University of Utah Research Foundation are appealing a decision rendered in March that found that the company's BRCA gene patents are "unpatentable."

A US Appeals Court overturned a lower court's decision in favor of Life Technologies predecessor firm Applera, clearing the way for it to pursue a claim for "substantial damages."

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.